JPRN-UMIN000003634
Completed
Phase 1
Phase I Study of definitive chemoradiotherapy with Docetaxel, CDDP and 5-FU for Unresectable or Recurrent Esophageal Cancer - Phase I Study of definitive chemoradiotherapy with Docetaxel, CDDP and 5-FU for Unresectable or Recurrent Esophageal Cancer
Department of Surgery, Graduate School of Medicine, Osaka University0 sites18 target enrollmentMay 18, 2010
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- advanced or recurrence esophageal carcinoma
- Sponsor
- Department of Surgery, Graduate School of Medicine, Osaka University
- Enrollment
- 18
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients have serious complications (heart disease, pulmonary fibrosis, interstitial pneumonia, hemorrhagic tendency and so on) 2\. active infection 3\. active synchronous malignancy 4\. esophagotracheal or esophagobronchial fistulas 5\. peripheral neuropathy or edema \>\= Grade 2 (CTCAE version3\) 6\. history of serious drug hypersensitivity 7\. brain metastasis 8\. pregnant or lactation women, or women with the possibility of the pregnancy and men who want let to pregnancy 9\. patients who are judged inappropriate for the entry into study by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 1
Phase I study of definitive chemoradiotherapy with paclitaxel, CDDP and 5-FU (PCF-RT) for clinical stage IA-IIIC esophageal canceresophageal cancerJPRN-UMIN000028589Osaka international cancer institute24
Recruiting
Phase 1
Phase I study of definitive CRT with paclitaxel, CDDP and 5-FU for clinical stage IA-IIIC esophageal cancer.(PCF-RT)Esophageal cancerJPRN-jRCTs051180082Yamamoto Sachiko24
Completed
Phase 1
Phase I trial of definitive chemoradiotherapy with paclitaxel, cisplatin, and 5-FU (PCF-RT) for esophageal canceresophageal cancerJPRN-UMIN000014927Aichi Cancer Center Hospital18
Active, Not Recruiting
Phase 2
Phase II study of definitive chemoradiotherapy with S-1 plus cisplatin for clinical stage IA esophageal squamous cell carcinoma. (SP-RT)JPRN-jRCTs051180078Yamamoto Sachiko76
Completed
N/A
A pilot study of definitive chemoradiotherapy using involved-field intensity-modulatd radiation therapy for patients with clinical stage IB-IIIC (non T4) esophageal carcinomaEsophageal neoplasmJPRN-UMIN000017668Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University12